Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - tablets extended release - sitagliptin as phosphate salt 50 mg; metformin hydrochloride 1000 mg - metformin - januet xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - tablets extended release - sitagliptin as phosphate salt 50 mg; metformin hydrochloride 500 mg - metformin - januet xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate

Israel - English - Ministry of Health

merck serono ltd - cladribine - tablets - cladribine 10 mg - cladribine - mavenclad 10mg tablets is indicated for the treatment of adult patients with highly active relapsing multiple sclerosis (ms) as defined by clinical or imaging features

Israel - English - Ministry of Health

merck serono ltd - follitropin alfa; lutropin alfa - solution for injection - lutropin alfa 150 iu / 0.48 ml; follitropin alfa 300 iu / 0.48 ml - follitropin alfa - pergoveris is indicated for the stimulation of follicular development in adult women with sever lh and fsh deficiency.in clinical trials, these patients were defined by an endogenous serum lh level < 1.2iu/l

Israel - English - Ministry of Health

merck serono ltd - interferon beta 1a - solution for injection - interferon beta 1a 88 mcg/ml - interferon beta-1a - rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. efficacy of rebif in chronic progressive multiplbe sclerosis has not been established.rebif is indicated for the treatment of patients with a single demyelinating event with an active inflammatory process, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis.these patients should have mri findings which are compatible with the diagnosis of multiple sclerosis.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

merck sharp & dohme, united kingdom - varicella virus vaccine live (oka-merck) - powder and solvent for suspension for injection - 1350 pfu/ml

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

merck generics rsa (pty) ltd - tablet - see ingredients - each tablet contains amiloride hydrochloride 5 mg hydrochlorothiazide 50 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

merck (pty) ltd - tablet - each tablet contains magnesium glycerophosphate 800 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

merck generics rsa (pty) ltd - syrup - see ingredients - each 5 ml syrup contains carbocisteine 250 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

merck generics rsa (pty) ltd - cream - see ingredients - each 1 g cream contains clotrimazole 10 mg